To clarify the potential role of PART1 in breast cancer, we studied the consequence of its knockdown and inhibition in the TNBC cell lines and a PDX, assessed its expression correlations with breast cancer patient survival, and evaluated its association with CSC populations. This evidence concerns the gene PART1 and breast carcinoma.